Reports Outline Cancer Gene Therapy Research from Henan University of Chinese Medicine (Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery).

Předmět:
Zdroj: Cancer Gene Therapy Week; 11/20/2023, p43-43, 1p
Abstrakt: A study conducted at Henan University of Chinese Medicine in China has developed a new method for efficient and safe delivery of miR-34a, a tumor suppressor gene, using a modified polyethylenimine (PEI) carrier called BA-PEI. The BA-PEI carrier demonstrated effective gene delivery and transfection performance, with a favorable compaction of miRNAs into positively charged nanoparticles. The study found that BA-PEI-mediated miR-34a gene transfection was more secure and effective than commercial transfection reagents, offering a novel approach for miR-34a-based gene therapy. This research provides valuable insights into cancer gene therapy and its potential applications. [Extracted from the article]
Databáze: Complementary Index